The aim of the present study was to evaluate the effects of PI3K p110α-E545K mutation on Akt pathway activation and cell survival in cervical cancer cell lines treated with radiation and/or cisplatin, and to determine the effects of PI3K pathway inhibition on the cellular response to radiation and cisplatin treatment. The gene discussed is PIK3CG; the disease is cervical carcinoma.